MannKind Expands Its Pipeline with the Acquisition of QrumPharma, Inc.

    NEXT STORY
    ALX Oncology Announces Updated Data from ASPEN-01, the Ongoing Phase 1b Study of ALX148, Showing Robust, Durable Activity in Patients with Non-Hodgkin Lymphoma
    PREV STORY
    Arcutis Announces Last Patient Completes Final Study Visit in DERMIS-1 and DERMIS-2 Pivotal Phase 3 Clinical Trials Evaluating ARQ-151 (Topical Roflumilast Cream) as a Potential Treatment for Plaque Psoriasis
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Genetic Testing 2018: Global Industry Forecasts to 2022 – Genomic Discoveries and Direct to Consumer Drive Growth, in a New Genetic Testing Industry

    Dublin, June 26, 2018 (GLOBE NEWSWIRE) -- The "The Global Genetic Testing Market By ...

    author_avatar
    NASDAQ Market News

    Curis to Release Fourth Quarter and Year End 2016 Financial Results and Hold Conference Call on March 9, 2017

    LEXINGTON, Mass., March 07, 2017 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), a biotechnology company ...

    author_avatar
    NASDAQ Market News

    Incysus Announces Appointment of Siraj Ali, MD, PhD to Its Scientific Advisory Board

    NEW YORK, Nov. 30, 2017 (GLOBE NEWSWIRE) -- Incysus, Ltd., a biopharmaceutical company focused ...

    author_avatar
    NASDAQ Market News